Revisiting COVID-19 vaccine hesitancy around the world using data from 23 countries in 2021.

Revisiting COVID-19 vaccine hesitancy around the world using data from 23 countries in 2021.
复制标题

DOI:
10.1038/s41467-022-31441-x
复制
发表时间:
2022-07-01
影响因子:
16.6
通讯作者:
El-Mohandes A
El-Mohandes A
中科院分区:
综合性期刊1区
文献类型:
--
作者:
Lazarus JV;Wyka K;White TM;Picchio CA;Rabin K;Ratzan SC;Parsons Leigh J;Hu J;El-Mohandes A

文献摘要

参考文献

被引文献

相似文献

尽管现有疫苗可有效降低死亡和严重疾病风险,但COVID-19大流行仍在继续影响日常生活,包括卫生系统的运作。据报道,负责疫苗接种运动的机构对COVID-19疫苗安全性、有效性、风险的误解以及不信任是导致疫苗犹豫的因素。本研究调查了2021年6月全球COVID-19疫苗犹豫情况。该研究调查了来自23个国家的1000名具有全国代表性的个人。对数据进行描述性分析,并使用加权多变量logistic回归来探讨与疫苗犹豫的关系。在这里,我们显示超过四分之三(75.2%)的23,000名受访者报告接受疫苗,高于一年前的71.5%。在所有国家,疫苗犹豫与对COVID-19疫苗安全性和科学缺乏信任以及对其有效性持怀疑态度有关。对疫苗持犹豫态度的应答者对所需的疫苗接种证明也高度抵触;分别有31.7%、20%、15%和14.8%的人赞成在国际旅行、室内活动、就业和公立学校入学时需要驾照。目前正在进行的COVID-19疫苗接种运动要想在未来成功提高覆盖率,仍需克服重大挑战。这些措施包括在报告疫苗信心较低的国家中增加疫苗接种,以及在低收入和中等收入国家扩大疫苗获取。疫苗犹豫是一项公共卫生挑战。在这里,作者通过一项包括来自23个国家的个人的调查,研究了2021年6月的COVID-19疫苗犹豫,并报告了与一年前相比的差异。
The COVID-19 pandemic continues to impact daily life, including health system operations, despite the availability of vaccines that are effective in greatly reducing the risks of death and severe disease. Misperceptions of COVID-19 vaccine safety, efficacy, risks, and mistrust in institutions responsible for vaccination campaigns have been reported as factors contributing to vaccine hesitancy. This study investigated COVID-19 vaccine hesitancy globally in June 2021. Nationally representative samples of 1,000 individuals from 23 countries were surveyed. Data were analyzed descriptively, and weighted multivariable logistic regressions were used to explore associations with vaccine hesitancy. Here, we show that more than three-fourths (75.2%) of the 23,000 respondents report vaccine acceptance, up from 71.5% one year earlier. Across all countries, vaccine hesitancy is associated with a lack of trust in COVID-19 vaccine safety and science, and skepticism about its efficacy. Vaccine hesitant respondents are also highly resistant to required proof of vaccination; 31.7%, 20%, 15%, and 14.8% approve requiring it for access to international travel, indoor activities, employment, and public schools, respectively. For ongoing COVID-19 vaccination campaigns to succeed in improving coverage going forward, substantial challenges remain to be overcome. These include increasing vaccination among those reporting lower vaccine confidence in addition to expanding vaccine access in low- and middle-income countries. Vaccine hesitancy is a public health challenge. Here the authors examine COVID-19 vaccine hesitancy in June 2021 using a survey including individuals from 23 countries, and report differences compared to a year earlier.
DOI: 10.1038/s43856-021-00027-x
发表时间: 2021
期刊: COMMUNICATIONS MEDICINE
影响因子: --
作者:
de Figueiredo, Alexandre;Larson, Heidi J
通讯作者: Larson, Heidi J
DOI: 10.12688/f1000research.24457.1
发表时间: 2020
期刊: F1000Research
影响因子: --
作者:
Hossain MM;Tasnim S;Sultana A;Faizah F;Mazumder H;Zou L;McKyer ELJ;Ahmed HU;Ma P
通讯作者: Ma P
DOI: 10.1371/journal.pone.0252892
发表时间: 2021
期刊: PloS one
影响因子: 3.7
作者:
Bicchieri C;Fatas E;Aldama A;Casas A;Deshpande I;Lauro M;Parilli C;Spohn M;Pereira P;Wen R
通讯作者: Wen R
DOI: 10.3390/ijerph18179342
发表时间: 2021-09-04
影响因子: --
作者:
AlShurman BA;Khan AF;Mac C;Majeed M;Butt ZA
通讯作者: Butt ZA
DOI: 10.1016/j.socscimed.2020.113638
发表时间: 2021-03
期刊: Social science & medicine (1982)
影响因子: --
作者:
Callaghan T;Moghtaderi A;Lueck JA;Hotez P;Strych U;Dor A;Fowler EF;Motta M
通讯作者: Motta M